Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hisataka Kobayashi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 47

Top Venues

Cancer science

Cancers

Molecular pharmaceutics

Bioconjugate chemistry

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Jan 1o 2005

United States

Chief Scientist/ Senoir Investigator :: Molecular Imaging Program

Publications

Takuya Kato, Connor Riahin, Aki Furusawa, Hiroshi Fukushima, Hiroaki Wakiyama, Shuhei Okuyama, Seiichiro Takao, Peter L Choyke, Marcin Ptaszek, Zeev Rosenzweig, Hisataka Kobayashi
Simultaneous multicolor imaging of lymph node chains using hydroporphyrin-doped near-infrared-emitting polymer dots. Nanomedicine (London, England) (2023)
Seiichiro Takao, Hiroshi Fukushima, A Paden King, Takuya Kato, Aki Furusawa, Shuhei Okuyama, Makoto Kano, Peter L Choyke, Freddy E Escorcia, Hisataka Kobayashi
Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700. Cancer science (2023)
Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Hiroaki Wakiyama, Seiichiro Takao, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Intratumoral interleukin-15 improves efficacy of near-infrared photoimmunotherapy. Molecular cancer therapeutics (2023)
Tadayuki Iwase, Kimihiro Ito, Takashi Nishimura, Kei Miyakawa, Akihide Ryo, Hisataka Kobayashi, Makoto Mitsunaga
Photoimmunotechnology as a powerful biological tool for molecular-based elimination of target cells and microbes, including bacteria, fungi and viruses. Nature protocols (2023)
Nanami L Miyazaki, Aki Furusawa, Peter C Black, Hisataka Kobayashi
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma. Cancers 15 (21) (2023)
Jiefu Jin, Ishwarya Sivakumar, Yelena Mironchik, Balaji Krishnamachary, Flonné Wildes, James D Barnett, Chien-Fu Hung, Sridhar Nimmagadda, Hisataka Kobayashi, Zaver M Bhujwalla, Marie-France Penet
PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model. Cancers 14 (3) (2022)
Hiroshi Fukushima, Siddharth S Matikonda, Syed Muhammad Usama, Aki Furusawa, Takuya Kato, Lenka Štacková, Petr Klán, Hisataka Kobayashi, Martin J Schnermann
Cyanine Phototruncation Enables Spatiotemporal Cell Labeling. Journal of the American Chemical Society 144 (25) (2022)
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy. Cancer immunology research 10 (11) (2022)
Hiroshi Fukushima, Baris Turkbey, Peter A Pinto, Aki Furusawa, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers. Cancers 14 (12) (2022)
Makoto Mitsunaga, Kimihiro Ito, Takashi Nishimura, Hironori Miyata, Kei Miyakawa, Takeshi Morita, Akihide Ryo, Hisataka Kobayashi, Yoshimitsu Mizunoe, Tadayuki Iwase
Antimicrobial strategy for targeted elimination of different microbes, including bacterial, fungal and viral pathogens. Communications biology 5 (1) (2022)
Jiefu Jin, James D Barnett, Balaji Krishnamachary, Yelena Mironchik, Catherine K Luo, Hisataka Kobayashi, Zaver M Bhujwalla
Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-α expressing cells in vitro and in vivo. Cancer science (2022)
James D Barnett, Jiefu Jin, Marie-France Penet, Hisataka Kobayashi, Zaver M Bhujwalla
Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice. Cancers 14 (15) (2022)
Takuya Kato, Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Seiichiro Takao, Peter L Choyke, Hisataka Kobayashi
Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response. Oncoimmunology 11 (1) (2022)
Takuya Kato, Ryuhei Okada, Aki Furusawa, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Comparison of the Effectiveness of IgG Antibody versus F(ab') 2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy. Molecular pharmaceutics 19 (10) (2022)
Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Takuya Kato, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers. Cancer immunology, immunotherapy : CII 71 (12) (2022)
Hideyuki Furumoto, Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts. Biomedicines 10 (4) (2022)
Fuyuki F Inagaki, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin. Pharmaceutics 14 (10) (2022)
Ryuhei Okada, Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Daiki Fujimura, Shuhei Okuyama, Hideyuki Furumoto, Hiroshi Fukushima, Peter L Choyke, Hisataka Kobayashi
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy. Cancer immunology, immunotherapy : CII 71 (8) (2022)
Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. Molecular cancer therapeutics (2022)
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Eisaku Kondo, Peter L Choyke, Hisataka Kobayashi
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer. Cancer science 113 (9) (2022)
Hideyuki Furumoto, Ryuhei Okada, Takuya Kato, Hiroaki Wakiyama, Fuyuki Inagaki, Hiroshi Fukushima, Shuhei Okuyama, Aki Furusawa, Peter C Black, Hisataka Kobayashi
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy. Cancers 14 (16) (2022)
Hiroshi Tazawa, Kunitoshi Shigeyasu, Kazuhiro Noma, Shunsuke Kagawa, Fuminori Sakurai, Hiroyuki Mizuguchi, Hisataka Kobayashi, Takeshi Imamura, Toshiyoshi Fujiwara
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment. Cancer science 113 (6) (2022)
Hisataka Kobayashi, Peter C Black
Future applications of and prospects for near-IR photoimmunotherapy: benefits and differences compared with photodynamic and photothermal therapy. Immunotherapy 13 (16) (2021)
Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy. Cancers 13 (11) (2021)
Takuya Kato, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Hiroshi Fukushima, Peter C Black, Hisataka Kobayashi
Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models. Molecular cancer therapeutics 20 (11) (2021)
Fuyuki F Inagaki, Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green. Cancer science 112 (3) (2021)
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Near infrared photoimmunotherapy of cancer; possible clinical applications. Nanophotonics 10 (12) (2021)
Yutaka Kurebayashi, Colleen P Olkowski, Kelly C Lane, Olga V Vasalatiy, Biying C Xu, Ryuhei Okada, Aki Furusawa, Peter C Black, Hisataka Kobayashi, Noriko Sato
Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression. Cancer research 81 (11) (2021)
Fuyuki F Inagaki, Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. Molecular pharmaceutics 18 (3) (2021)
Takuya Kato, Ryuhei Okada, Yuto Goto, Aki Furusawa, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Dagane Daar, Baris Turkbey, Peter L Choyke, Hideo Takakura, Osamu Inanami, Mikako Ogawa, Hisataka Kobayashi
Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy. ACS pharmacology & translational science 4 (5) (2021)
Adrian Rosenberg, Daiki Fujimura, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice. Molecular imaging 19 (2021)
Florian van Beurden, Danny M van Willigen, Borivoj Vojnovic, Matthias N van Oosterom, Oscar R Brouwer, Henk G van der Poel, Hisataka Kobayashi, Fijs W B van Leeuwen, Tessa Buckle
Multi-Wavelength Fluorescence in Image-Guided Surgery, Clinical Feasibility and Future Perspectives. Molecular imaging 19 (2021)
Syed Muhammad Usama, Fuyuki Inagaki, Hisataka Kobayashi, Martin J Schnermann
Norcyanine-Carbamates Are Versatile Near-Infrared Fluorogenic Probes. Journal of the American Chemical Society 143 (15) (2021)
Ryuhei Okada, Aki Furusawa, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama, Hideyuki Furumoto, Hiroshi Fukushima, Peter L Choyke, Hisataka Kobayashi
Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model. Cancer science 112 (8) (2021)
Adrian Rosenberg, Fuyuki F Inagaki, Takuya Kato, Ryuhei Okada, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Wound healing after excision of subcutaneous tumors treated with near-infrared photoimmunotherapy. Cancer medicine 9 (16) (2020)
Yuko Nishinaga, Kazuhide Sato, Hirotoshi Yasui, Shunichi Taki, Kazuomi Takahashi, Misae Shimizu, Rena Endo, Chiaki Koike, Noriko Kuramoto, Shota Nakamura, Takayuki Fukui, Hiroshi Yukawa, Yoshinobu Baba, Mika K Kaneko, Toyofumi F Chen-Yoshikawa, Hisataka Kobayashi, Yukinari Kato, Yoshinori Hasegawa
Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin. Cells 9 (4) (2020)
Yu A Nakamura, Shuhei Okuyama, Aki Furusawa, Tadanobu Nagaya, Daiki Fujimura, Ryuhei Okada, Yasuhiro Maruoka, Philip C Eclarinal, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy through bone. Cancer science 110 (12) (2019)
Hisataka Kobayashi, Gary L Griffiths, Peter L Choyke
Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs). Bioconjugate chemistry 31 (1) (2019)
Takashi Nishimura, Makoto Mitsunaga, Ryoichi Sawada, Masayuki Saruta, Hisataka Kobayashi, Noriko Matsumoto, Toru Kanke, Hiroyuki Yanai, Koji Nakamura
Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody. Cancer medicine 8 (18) (2019)
Hisataka Kobayashi, Peter L Choyke
Near-Infrared Photoimmunotherapy of Cancer. Accounts of chemical research 52 (8) (2019)
Mohammad R Siddiqui, Reema Railkar, Thomas Sanford, Daniel R Crooks, Michael A Eckhaus, Diana Haines, Peter L Choyke, Hisataka Kobayashi, Piyush K Agarwal
Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT). Scientific reports 9 (1) (2019)
Ryuhei Okada, Yasuhiro Maruoka, Aki Furusawa, Fuyuki Inagaki, Tadanobu Nagaya, Daiki Fujimura, Peter L Choyke, Hisataka Kobayashi
The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy. Bioconjugate chemistry 30 (10) (2019)
Fusa Ogata, Tadanobu Nagaya, Yasuhiro Maruoka, Joshua Akhigbe, Adam Meares, Melissa Y Lucero, Andrius Satraitis, Daiki Fujimura, Ryuhei Okada, Fuyuki Inagaki, Peter L Choyke, Marcin Ptaszek, Hisataka Kobayashi
Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer. Bioconjugate chemistry 30 (1) (2018)
Yasuhiro Maruoka, Tadanobu Nagaya, Kazuhide Sato, Fusa Ogata, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near Infrared Photoimmunotherapy with Combined Exposure of External and Interstitial Light Sources. Molecular pharmaceutics 15 (9) (2018)
Tadanobu Nagaya, Shuhei Okuyama, Fusa Ogata, Yasuhiro Maruoka, Peter L Choyke, Hisataka Kobayashi
Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 22 (3) (2018)
Tadanobu Nagaya, Shuhei Okuyama, Fusa Ogata, Yasuhiro Maruoka, Peter L Choyke, Hisataka Kobayashi
Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer. Cancer science 109 (6) (2018)
Yasuhiro Maruoka, Tadanobu Nagaya, Yuko Nakamura, Kazuhide Sato, Fusa Ogata, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. Molecular pharmaceutics 14 (12) (2017)

Hisataka Kobayashi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hisataka Kobayashi